As PSCs do not express the MET receptor, inhibition of the HGF/MET axis by the Combo treatment cannot directly influence the PSC status, but must be the consequence of a cross-talk between the tumor and the stroma compartment, which probably occurs through TNC. Here, HGF is linked to neoplasm.